Novel Presentation of Terminal Ileitis Associated with Secukinumab Therapy
Inflammatory bowel disease (IBD) and psoriasis are chronic inflammatory immune-mediated diseases. The interleukin-23- (IL23-) T helper (Th)17 pathway has been implicated in their pathogenesis, with multiple biologic therapies targeting this pathway. IL-17, the main proinflammatory cytokine produced...
Main Authors: | Aciel Ahmed Shaheen, Ismail Hader, Zakaria Aqel |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2021-01-01
|
Series: | Case Reports in Gastrointestinal Medicine |
Online Access: | http://dx.doi.org/10.1155/2021/5213876 |
Similar Items
-
Capecitabine-Associated Terminal Ileitis
by: Irene E.G. van Hellemond, et al.
Published: (2018-10-01) -
Capecitabine-induced terminal ileitis
by: Aboelkhair Mohammad Al-Gahmi, et al.
Published: (2012-11-01) -
Ileítis aguda Acute ileitis
by: E. Garrido Gómez, et al.
Published: (2009-04-01) -
Terminal Ileitis due to Yersinia Infection: An Underdiagnosed Situation
by: John K. Triantafillidis, et al.
Published: (2020-01-01) -
Ileitis crónica
by: Alberto Albornoz Plata
Published: (1956-02-01)